Log in to save to my catalogue

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically i...

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_030d9eaaddcb4277b98b1372dc2e3bc7

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study

About this item

Full title

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study

Publisher

London: BioMed Central Ltd

Journal title

Critical care (London, England), 2021-09, Vol.25 (1), p.1-335, Article 335

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) emerged as important fungal complications in patients with COVID-19-associated severe acute respiratory failure (ARF). Whether mould active antifungal prophylaxis (MAFP) can prevent CAPA remains elusive so far. Methods In this observational study, we included all...

Alternative Titles

Full title

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_030d9eaaddcb4277b98b1372dc2e3bc7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_030d9eaaddcb4277b98b1372dc2e3bc7

Other Identifiers

ISSN

1364-8535

E-ISSN

1364-8535,1366-609X,1466-609X

DOI

10.1186/s13054-021-03753-9

How to access this item